4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-24-002130
Options or other derivatives
- President, CMO acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Huang Jane President, CMO | 2024-03-01 | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | D | ||
Loading xslF345X05/primarydocument.xml…